InvestorsHub Logo
Followers 116
Posts 1906
Boards Moderated 0
Alias Born 11/22/2017

Re: abeta post# 225450

Saturday, 05/04/2019 12:33:56 PM

Saturday, May 04, 2019 12:33:56 PM

Post# of 718605
Abeta,

Linda Liau says the following about treatment patients and pseudo-progression (Dec.20 2018 -Campbell Lecturer Details New Directions in Brain Cancer Treatment):

Liau also described one of the main challenges is measuring whether an immunotherapy drug is working against a glioblastoma tumor. After injections of these drugs, a tumor may enlarge (“pseudoprogression”) for possibly 6 months before it gets smaller. Therefore, standard imaging techniques, such as MRI, to assess whether tumors are growing or shrinking in response to treatment are not as sufficient in brain cancer.


https://www.goodmancampbell.com/in-the-news/campbell-lecturer-details-new-directions-in-brain-cancer-treatment
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News